Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)
Status:
Unknown status
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Valproic acid, as a single agent is
effective in the treatment of Chronic Lymphocytic Leukemia which has relapsed or is
refractory to therapy with standard drugs.
Phase:
N/A
Details
Lead Sponsor:
All India Institute of Medical Sciences, New Delhi